
Ethomix provides objective, personalized insights from everyday movement to enable earlier interventions and better care. Its patented behavioural fingerprints capture real-world activity, which its AI platform converts into physiologically grounded digital biomarkers for patients, pharma, and health systems. The system supports remote monitoring and integrates with wearable and digital health platforms to support real-world evidence and clinical trials. Originating as a spinout from Imperial College London, Ethomix combines published research and clinical data to power predictive models. The market focus spans healthcare providers, payers, and life sciences seeking outcome-driven measurement.

Ethomix provides objective, personalized insights from everyday movement to enable earlier interventions and better care. Its patented behavioural fingerprints capture real-world activity, which its AI platform converts into physiologically grounded digital biomarkers for patients, pharma, and health systems. The system supports remote monitoring and integrates with wearable and digital health platforms to support real-world evidence and clinical trials. Originating as a spinout from Imperial College London, Ethomix combines published research and clinical data to power predictive models. The market focus spans healthcare providers, payers, and life sciences seeking outcome-driven measurement.